Leukotriene receptor antagonists for chronic urticaria: A systematic review

Allergy, Asthma and Clinical Immunology

Volumn 10, Issue 1, 2014, Pages

  de Silva, Nipun L ^a   Damayanthi, Hasitha ^a   Rajapakse, Anoja C ^b   Rodrigo, Chaturaka ^a   Rajapakse, Senaka ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b KING S MILL HOSPITAL   (United Kingdom)

Author keywords

Antihistamines; Chronic urticaria; Leukotreine; Leukotreine receptor antagonists; Montelukast; Zafirlukast

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CETIRIZINE; DESLORATADINE; FEXOFENADINE; HYDROXYZINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ZAFIRLUKAST;

ANGIONEUROTIC EDEMA; CHRONIC URTICARIA; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MONOTHERAPY; PRURITUS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; URTICARIA; VISUAL ANALOG SCALE;

EID: 84900344142     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-10-24     Document Type: Review

References (24)

1. Kanani A, Schellenberg R, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol 2011, 7(1):S9. 10.1186/1710-1492-7-9, 3245442, 22165855.
2. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000, 105(4):664-672. 10.1067/mai.2000.105706, 10756214.
3. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004, 114(3):465-474. quiz 475, 10.1016/j.jaci.2004.02.049, 15356542.
4. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64(10):1417-1426. 10.1111/j.1398-9995.2009.02179.x, 19772512.
5. Altman K, Chang C. Pathogenic intracellular and autoimmune mechanisms in Urticaria and Angioedema. Clin Rev Allergy Immunol 2012, 1-16.
6. Greaves M. Management of urticaria. Hosp Med 2000, 61(7):463-469.
7. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009, 64(10):1427-1443. 10.1111/j.1398-9995.2009.02178.x, 19772513.
8. Nam YH, Kim JH, Jin HJ, Hwang EK, Shin YS, Ye YM, Park HS. Effects of omalizumab treatment in patients with refractory chronic urticaria. Allergy, Asthma and Immunology Research 2012, 4(6):357-361.
9. Riccioni G, Bucciarelli T, Mancini B, Di Ilio C, D'Orazio N. Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem 2007, 14(18):1966-1977. 10.2174/092986707781368522, 17691939.
10. McBayne TO, Siddall OM. Montelukast treatment of urticaria. Ann Pharmacother 2006, 40(5):939-942. 10.1345/aph.1G006, 16670370.
11. Di Lorenzo G, D'Alcamo A, Rizzo M, Leto-Barone MS, Lo Bianco C, Ditta V, Politi D, Castello F, Pepe I, Rini G. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. Journal of Asthma and Allergy 2009, 2:9-16.
12. Agcaoili ML, Sumpaico MW, Aleta LA, Recto MP, Abong JM. Montelukast in the treatment of chronic Urticaria: a randomized double blind, placebocontrolled study. Ann Allergy Asthma Immunol 2011, 107(5):Supplement 1.
13. Di Lorenzo G, Pacor ML, Mansueto P, Esposito Pellitteri M, Lo Bianco C, Ditta V, Martinelli N, Rini GB. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 2004, 114(3):619-625. 10.1016/j.jaci.2004.06.018, 15356567.
14. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 2004, 34(9):1401-1407. 10.1111/j.1365-2222.2004.02019.x, 15347373.
15. Kosnik M, Subic T. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria. Respir Med 2011, 105(SUPPL. 1):S84-S88.
16. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002, 110(3):484-488. 10.1067/mai.2002.126676, 12209099.
17. Reimers A, Pichler C, Helbling A, Pichler WJ, Yawalkar N. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002, 32(12):1763-1768. 10.1046/j.1365-2222.2002.01536.x, 12653169.
18. Nettis E, Pannofino A, Cavallo E, Ferrannini A, Tursi A. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. J Allergy Clin Immunol 2003, 112(1):212-213. 10.1067/mai.2003.1559, 12847504.
19. Pacor ML, Di G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria: a double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001, 31(10):1607-1614. 10.1046/j.1365-2222.2001.01189.x, 11678862.
20. Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004, 113(1):134-140. 10.1016/j.jaci.2003.10.002, 14713918.
21. Wan KS. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. J Dermatol Treat 2009, 20(4):194-197.
22. Godse KV. Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J Dermatol Venereol Leprol 2006, 72(4):312-314. 10.4103/0378-6323.26735, 16880585.
23. Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 2001, 137(1):99-100.
24. Leukotriene receptor antagonists. British National Formulary 2013, 198-199. London: BMJ Group and the Royal Pharmaceutical Society of Great Britain.